← FDA DRUG APPROVALS

FDA ANDA · ANDA088729

HYDRALAZINE HYDROCHLORIDE

Sponsor: TP ANDA HOLDINGS

APPLICATION
ANDA088729
TYPE
ANDA
ORIGINAL APPROVAL
1985-04-11
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDRALAZINE HYDROCHLORIDEDiscontinued
HYDRALAZINE HYDROCHLORIDE 100MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 13AP
1994-12-23Manufacturing (CMC) · Supplement 12AP
1994-10-11Manufacturing (CMC) · Supplement 11AP
1992-04-03Manufacturing (CMC) · Supplement 8AP
1992-04-03Manufacturing (CMC) · Supplement 10AP
1987-03-31Manufacturing (CMC) · Supplement 5AP
1985-08-09Manufacturing (CMC) · Supplement 1AP
1985-04-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →